Our study reveals that in NSCLC cells, upregulated PRMT3 promotes IDO1 expression by methylating TFAP2A, thereby activating the tumor’s intrinsic Kyn metabolism and mediating the development of radiation resistance. Here, IDO1 is linked to non-small cell lung carcinoma.